Hostname: page-component-788cddb947-xdx58 Total loading time: 0 Render date: 2024-10-12T22:24:57.457Z Has data issue: false hasContentIssue false

Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment

Published online by Cambridge University Press:  11 June 2010

M A Buchanan*
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
A Rai
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
P R Prinsley
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
*
Address for correspondence: Mr M A Buchanan, Beck House, 137B Cambridge Road, Great Shelford, Cambridge CB22 5JJ, UK. E-mail: malcolm_buchanan123@hotmail.com

Abstract

Objectives:

To evaluate patient satisfaction and symptom improvement following treatment of Ménière's disease with the Meniett® device.

Methods:

Retrospective, questionnaire-based audit and analysis of unilateral Ménière's disease patients’ records, following on from a previous study from our departments on intra-tympanic gentamicin for Ménière's disease, using the Vertigo Symptom Scale and Glasgow Benefit Inventory as outcome measures.

Results:

Of 33 consecutive patients treated with the Meniett® device for four to six weeks, 30 responded to the questionnaires (90.9 per cent). Respondents’ mean Vertigo Symptom Scale score was 0.7 (range 0–2.1), and their mean Glasgow Benefit Inventory general subscale score was 24.1. Nineteen (63.3 per cent) patients felt that the device had alleviated their vertigo and tinnitus.

Conclusions:

This is the first UK study of the effectiveness of the Meniett® device in treating Ménière's disease. It shows that the Meniett® device is a well tolerated, useful and minimally invasive means of treating Ménière's disease after medical treatment has failed, and before more potentially cochleo- and vestibulo-toxic therapies and invasive procedures are utilised.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Schuknecht, HF. Pathophysiology of Meniere's disease. Otolaryngol Clin North Am 1975;8:507–14CrossRefGoogle ScholarPubMed
2Tsuji, K, Velazquez-Villasenor, L, Rauch, SD, Glynn, RJ, Wall, C, Merchant, SN. Temporal bone studies of the human peripheral vestibular system. Meniere's disease. Ann Otol Rhinol Laryngol Suppl 2000;181:2631CrossRefGoogle ScholarPubMed
3Evans, KL, Baldwin, DL, Bainbridge, D, Morrison, AW. Immune status in patients with Meniere's disease. Arch Otorhinolaryngol 1988;245:287–92CrossRefGoogle ScholarPubMed
4Riente, L, Bongiorni, F, Nacci, A, Migliorini, P, Segnini, G, Delle Sedie, A et al. Antibodies to inner ear antigens in Meniere's disease. Clin Exp Immunol 2004;135:159–63CrossRefGoogle ScholarPubMed
5Bernstein, JM, Shanahan, TC, Schaffer, FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol 1996;116:666–71CrossRefGoogle ScholarPubMed
6Fransen, E, Verstreken, M, Verhagen, WI, Wuyts, FL, Huygen, PL, D'Haese, P et al. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999;8:1425–9CrossRefGoogle ScholarPubMed
7Furstenberg, AC, Lashmet, FH, Lathrop, F. Meniere's symptom complex: medical treatment. 1934. Ann Otol Rhinol Laryngol 1992;101:2031CrossRefGoogle ScholarPubMed
8Understanding Meniere's Disease. The Disease and its Treatments. Jacksonville, Florida: Medtronic, 2005Google Scholar
9Densert, B, Densert, O, Arlinger, S, Sass, K, Odkvist, L. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Meniere's disease: a clinical placebo-controlled study. Am J Otol 1997;18:726–33Google ScholarPubMed
10Densert, B, Densert, O. Overpressure in treatment of Meniere's disease. Laryngoscope 1982;92:1285–92CrossRefGoogle ScholarPubMed
11Smith, WK, Sandooram, D, Prinsley, PR. Intratympanic gentamicin treatment in Meniere's disease: patients’ experiences and outcomes. J Laryngol Otol 2006;120:730–5CrossRefGoogle ScholarPubMed
12Monsell, EM, Balkany, TA, Gates, GA, Goldenberg, RA, Meyerhoff, WL, House, JW. Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181–5Google Scholar
13Yardley, L, Masson, E, Verschuur, C, Haacke, N, Luxon, L. Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale. J Psychosom Res 1992;36:731–41CrossRefGoogle ScholarPubMed
14Robinson, K, Gatehouse, S, Browning, GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 1996;105:415–22CrossRefGoogle ScholarPubMed
15Torok, N. Old and new in Meniere disease. Laryngoscope 1977;87:1870–7CrossRefGoogle ScholarPubMed
16Sakikawa, Y, Kimura, RS. Middle ear overpressure treatment of endolymphatic hydrops in guinea pigs. ORL J Otorhinolaryngol Relat Spec 1997;59:8490CrossRefGoogle ScholarPubMed
17Dornhoffer, JL, Danner, C, Zhou, L, Li, S. Atrial natriuretic peptide receptor upregulation in the rat inner ear. Ann Otol Rhinol Laryngol 2002;111:1040–4CrossRefGoogle ScholarPubMed
18James, AL, Burton, MJ. Betahistine for Meniere's disease or syndrome. Cochrane Database Syst Rev 2001;(1):CD001873Google ScholarPubMed
19Lange, G, Maurer, J, Mann, W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114:102–5CrossRefGoogle ScholarPubMed
20Boleas-Aguirre, MS, Lin, FR, Della Santina, CC, Minor, LB, Carey, JP. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008;29:33–8CrossRefGoogle ScholarPubMed
21Silverstein, H, Norrell, H, Rosenberg, S. The resurrection of vestibular neurectomy: a 10-year experience with 115 cases. J Neurosurg 1990;72:533–9CrossRefGoogle ScholarPubMed
22Snow, JB Jr, Kimmelman, CP. Assessement of surgical procedures for Meniere's disease. Laryngoscope 1979;89:737–47CrossRefGoogle ScholarPubMed
23Gates, GA, Green, JD Jr, Tucci, DL, Telian, SA. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease. Arch Otolaryngol Head Neck Surg 2004;130:718–25CrossRefGoogle ScholarPubMed
24Gates, GA, Verrall, A, Green, JD Jr, Tucci, DL, Telian, SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006;132:1311–16CrossRefGoogle ScholarPubMed
25Odkvist, LM, Arlinger, S, Billermark, E, Densert, B, Lindholm, S, Wallqvist, J. Effects of middle ear pressure changes on clinical symptoms in patients with Meniere's disease – a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl 2000;543:99101CrossRefGoogle ScholarPubMed
26Thomsen, J, Sass, K, Odkvist, L, Arlinger, S. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005;26:6873CrossRefGoogle ScholarPubMed
27Alva, B. Treatment of Meniere's disease with the ‘Modified Seigel's Device’ – How I do it. ENT News 2008;17:68–9Google Scholar
28Smith, WK, Sankar, V, Pfleiderer, AG. A national survey amongst UK otolaryngologists regarding the treatment of Meniere's disease. J Laryngol Otol 2005;119:102–5CrossRefGoogle ScholarPubMed
29LaRouere, MJ, Zappia, JJ, Graham, MD. Titration streptomycin therapy in Meniere's disease: current concepts. Am J Otol 1993;14:474–7Google ScholarPubMed
30Pulec, JL. Labyrinthectomy: indications, technique and results. Laryngoscope 1974;84:1552–73CrossRefGoogle ScholarPubMed